Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 3
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review.
Dong Y, Xu J, Sun B, Wang J, Wang Z. Dong Y, et al. Mol Diagn Ther. 2022 Mar;26(2):203-227. doi: 10.1007/s40291-021-00568-w. Epub 2022 Mar 10. Mol Diagn Ther. 2022. PMID: 35266116 Free PMC article. Review.
Further, MET alteration (MET amplification/overexpression) may be an actionable target in gastric cancer and papillary renal cell carcinoma....
Further, MET alteration (MET amplification/overexpression) may be an actionable target in gastric cancer and papillary renal
Recommendations for the Management of Rare Kidney Cancers.
Giles RH, Choueiri TK, Heng DY, Albiges L, Hsieh JJ, Linehan WM, Pal S, Maskens D, Paseman B, Jonasch E, Malouf G, Molina AM, Pickering L, Shuch B, Srinivas S, Srinivasan R, Tannir NM, Bex A. Giles RH, et al. Eur Urol. 2017 Dec;72(6):974-983. doi: 10.1016/j.eururo.2017.06.040. Epub 2017 Jul 16. Eur Urol. 2017. PMID: 28720391 Review.
Diagnostic Accuracy of MRI for Detection of Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Chiarello MA, Mali RD, Kang SK. Chiarello MA, et al. AJR Am J Roentgenol. 2018 Oct;211(4):812-821. doi: 10.2214/AJR.17.19462. Epub 2018 Jul 31. AJR Am J Roentgenol. 2018. PMID: 30063398 Free PMC article.
OBJECTIVE: The objective of our study was to perform a systematic review and meta-analysis of the diagnostic performance of MRI in differentiation of papillary renal cell carcinoma (RCC) from other renal masses. MATERIALS AND METHODS: We performed sear …
OBJECTIVE: The objective of our study was to perform a systematic review and meta-analysis of the diagnostic performance of MRI in different …
A comparison of the prognosis of papillary and clear cell renal cell carcinoma: Evidence from a meta-analysis.
Deng J, Li L, Xia H, Guo J, Wu X, Yang X, Hong Y, Chen Q, Hu J. Deng J, et al. Medicine (Baltimore). 2019 Jul;98(27):e16309. doi: 10.1097/MD.0000000000016309. Medicine (Baltimore). 2019. PMID: 31277173 Free PMC article.
A total of 35,832 patients were included. Of these patients, 6907 patients were diagnosed with papillary renal cell carcinoma, and 28,925 patients were diagnosed with clear cell renal cell carcinoma. ...
A total of 35,832 patients were included. Of these patients, 6907 patients were diagnosed with papillary renal cell
Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, Linehan WM, Maher ER, Merino MJ, Offit K, Reuter VE, Shuch B, Coleman JA. Carlo MI, et al. Eur Urol. 2019 Dec;76(6):754-764. doi: 10.1016/j.eururo.2019.06.015. Epub 2019 Jul 18. Eur Urol. 2019. PMID: 31326218 Free PMC article.
Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.
Jishnu PV, Jayaram P, Shukla V, Varghese VK, Pandey D, Sharan K, Chakrabarty S, Satyamoorthy K, Kabekkodu SP. Jishnu PV, et al. Clin Exp Metastasis. 2020 Feb;37(1):31-46. doi: 10.1007/s10585-019-10013-2. Epub 2019 Dec 7. Clin Exp Metastasis. 2020. PMID: 31813069
The subgroup analysis showed that lung cancer, breast cancer and papillary renal cell carcinoma (p < 0.001) have a negative association with the survival of patients. ...

The subgroup analysis showed that lung cancer, breast cancer and papillary renal cell carcinoma (p < 0.001) h